Two kinds of firms do this as a specialty: lead generation agencies with genuine healthcare practices, and Build, Run, Own consultancies. Enquirer Consulting Group is the second kind: we design, build and run outbound sales engines for US pharmaceutical and medical companies over a fixed four-month engagement, then hand the engine and a trained operator to your team. The difference to check for is what you own at the end.
COMPARISON · UPDATED JULY 2026
The best outbound sales partners for US medical and pharma companies in 2026
There are five ways an established US medical or pharma company gets outbound sales built in 2026, from outsourcing to software to building in-house. This page compares them honestly: what each one is, what it costs you in time and risk, and what you are left owning at the end.
One disclosure before the list. Enquirer Consulting Group sells the fifth model. For plenty of buyers, one of the other four is the right answer, and we say which.
THE SHORT ANSWERS
The short answers.
- Fastest start: a lead generation agency. You rent the result.
- Lowest cash cost: software, if you already employ someone who runs outbound daily.
- Most control: building in-house, if you can carry the months of hiring and ramp.
- Field-rep coverage at scale: a contract sales organization.
- Owning the working unit without carrying the build: a Build, Run, Own engagement.
HOW WE COMPARED
How we compared the five models.
We ranked nothing. Instead we compared every model on the four questions buyers actually decide on: how fast it produces qualified conversations, what the commitment and cost shape looks like, who carries the operating risk, and what you own when the engagement ends. The examples and trade-offs come from running outbound in US medical and pharma, where buyers are physicians, imaging directors, department chairs, procurement and biomedical engineering, and where generic B2B outreach reliably fails. If you want the fuller decision framework, we wrote a separate guide on how to choose an outbound sales partner.
01
The lead generation agency.
A lead generation agency, often called an SDR agency, runs cold email and LinkedIn campaigns for you and books meetings, usually on a monthly retainer. It is the fastest way to find out whether outbound can work for your product, and the good ones bring real infrastructure and process. The trade is ownership. The domains, the data, the sequences and the learned know-how usually stay with the agency, so the pipeline stops when the retainer stops. In medical and pharma the other watch-item is sector literacy: an agency that mostly sells for software companies will burn your market with the wrong message.
Choose this model if you want a short-term surge or a low-commitment test. Ask what you keep if you leave, before you sign.
02
The contract sales organization (CSO).
A contract sales organization supplies trained sales representatives, often by the territory, and runs them as an outsourced field force. For a pharma company that needs reps calling on HCPs at scale, this is the established model, and the large CSOs are genuinely good at it. It is also the heaviest option on this page. A CSO engagement is built for scale, priced for scale, and shaped around rep headcount, not around a digital engine. If what you actually need is a steady flow of qualified conversations for one or two product lines in a niche, a CSO is usually more machine than the job requires. The reps also remain the CSO's asset, not yours.
Choose this model if the problem is field coverage. If the problem is top-of-funnel reach, keep reading.
03
Building it in-house, with hires or staffed SDRs.
Building in-house means hiring or staffing your own SDR function: the people, the data tools, the sending infrastructure, the management. You get full control and deep product knowledge, and everything you build is yours from day one. The cost is time and carry. Recruiting, tooling and ramp reliably take months before the first meeting lands. A first SDR hire needs a manager and a playbook most medical mid-market companies do not have in the building. If the hire misses, you start over. Staffing firms, fractional hires and revenue operations (RevOps) talent marketplaces shorten the hiring, but they leave the management and the playbook problem with you.
Choose this model if outbound is already proven in your market and you are industrializing it. It is a hard way to run the first experiment.
04
Software and AI SDR platforms.
The do-it-yourself route: outbound sequencing platforms, data providers, and increasingly AI SDR products that write and send for you. The economics are the best on this page, and for a team that already employs someone who lives in this work daily, good tooling is enough. The failure mode is the missing operator. The software sends whatever you load into it, and in a regulated, relationship-led market the list quality, the message and the deliverability discipline are the whole game. Most medical companies that buy the tool without the operator get silence, or worse, a burned domain.
Choose this model if you have the person. The tool does not replace them.
05
The Build, Run, Own partner.
A Build, Run, Own partner stands up the complete outbound unit, runs it in market to prove it on live numbers, then hands the whole thing to your team: the domains, the data, the dashboards, the playbook and a trained operator to run it. It is a fixed engagement rather than an open-ended retainer, so the model only works if the results are real by handover. This is the model ECG sells, on a fixed four-month engagement for US medical and pharma companies; it is explained in full on the Build, Run, Own page. Lifetime across our client campaigns the engine has generated 3,500+ qualified conversations. On recent US medical campaigns specifically, that includes 260+ qualified conversations from under 10,000 targeted LinkedIn invitations, as of June 2026. A qualified conversation means a positive or interested reply, not a booked meeting; we label our numbers precisely because this market checks. Our named clients talk about it on camera on our resources page.
Choose this model if you want what the in-house route produces without carrying the build yourself, and what the agency route produces without the dependency.
THE TABLE
The five models, side by side.
| Model | Speed to first conversations | Commitment and cost shape | Who carries the operating risk | What you own at the end |
|---|---|---|---|---|
| Lead generation agency | Fast | Ongoing monthly retainer | Shared | Usually little |
| Contract sales organization | Slow to start, built for scale | Long contract, priced for scale | The CSO, priced in | The relationships, not the team |
| In-house build | Slow, hiring first | Permanent fixed payroll cost | You | Everything, eventually |
| Software and AI SDR | Fast to send, slow to land | Subscriptions, lowest cash cost | You | The tool stack |
| Build, Run, Own | Fast, from warmed assets | One fixed project fee over four months, then optional | The partner during the build, you after handover | The working unit, including the operator |
FAQ
Frequently asked questions.
The table shows each model's cost shape, because that is comparable; specific numbers are not. Each model is scoped to your market, your product lines and your gaps. We price a Build, Run, Own engagement live on a call once we understand the scope, and we would be cautious of any partner, in any model, who quotes a price before understanding yours.
They solve different problems, and both are forms of outbound sales outsourcing. A CSO supplies field reps; an agency supplies top-of-funnel conversations. For most mid-market medical companies the missing piece is systematic reach, which points to the agency or Build, Run, Own models. A CSO earns its cost when the job is rep coverage at scale.
The end state. An agency runs outbound for you for as long as you pay. A Build, Run, Own partner is contracted to make itself unnecessary: the engagement ends with your team owning the working unit, and anything after that, like a managed service, is optional.
Enquirer Consulting Group, the consultancy behind the Build, Run, Own model. We publish it because buyers ask us to compare these options on nearly every first call. When one of the other four models fits your company better, you should pick it.
See which model fits your company.
The free readiness review is a specific read on how you grow today and where outbound would add the most, whichever model you choose. No deck, no pitch, one page of findings.
Get your free readiness reviewOr browse the guides.